# The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020, Paragraph 17

Extent: E+W

The applicant must provide details of whether—
(a) for the patients who are accustomed to accessing pharmaceutical services at the existing premises, the location of the new premises is significantly less accessible,
(b) the same pharmaceutical services will be provided at the new premises as are provided at the listed premises, and
(c) the provision of pharmaceutical services will be continuous or interrupted and the reasons for any interruption.

---
Source: https://www.legislation.gov.uk/wsi/2020/1073/schedule/2/paragraph/17 (the official version)
Page: https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020/schedule-2/paragraph-17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.